Literature DB >> 6140865

Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.

C T Gualtieri, D Quade, R E Hicks, J P Mayo, S R Schroeder.   

Abstract

Of 41 children, adolescents, and young adults who were withdrawn from chronic neuroleptic treatment, 18 developed tardive dyskinesia, withdrawal dyskinesia, nondyskinetic withdrawal symptoms, or transient behavior deterioration. Development of neuroleptic-related problems seemed to be associated with cumulative neuroleptic dose and possibly with the sex of the subject. Only 12 of the 41 subjects required resumption of neuroleptic treatment after a prolonged trial withdrawal period.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6140865     DOI： 10.1176/ajp.141.1.20

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  8 in total

Review 1.  Typical neuroleptics in child and adolescent psychiatry.

Authors:  C Gillberg
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

2.  Effect of extended depot fluphenazine treatment and withdrawal on social and other behaviors of Cebus apella monkeys.

Authors:  K Lifshitz; R T O'Keeffe; K L Lee; G S Linn; D Mase; J Avery; E S Lo; T B Cooper
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.

Authors:  Jessica A Hellings; Gregory Reed; Sharon E Cain; Xinghua Zhou; Francis X Barth; Michael G Aman; Gladys I Palaguachi; Dmytro Mikhnev; Rujia Teng; Rebecca Andridge; Marilyn Logan; Merlin G Butler; Joan C Han
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-03       Impact factor: 2.576

Review 4.  Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner.

Authors:  N J Carrey; D M Wiggins; R P Milin
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

5.  Tardive dyskinesia and pregnancy and delivery complications.

Authors:  M H El-DeFrawi; G Hirsch; A Jurkowicz; T J Craig
Journal:  Child Psychiatry Hum Dev       Date:  1996

6.  Use of methylphenidate in the treatment of children with autistic disorder.

Authors:  H Quintana; B Birmaher; D Stedge; S Lennon; J Freed; J Bridge; L Greenhill
Journal:  J Autism Dev Disord       Date:  1995-06

Review 7.  Tardive dyskinesia.

Authors:  D E Casey
Journal:  West J Med       Date:  1990-11

Review 8.  Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.

Authors:  Danielle Coppola; Leo J Russo; Robert F Kwarta; Ruana Varughese; Juergen Schmider
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.